Market Size of Global Non-vascular Stents Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 5.20 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | High |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Non-vascular Stents Market Analysis
The non-vascular stents market studied is anticipated to grow with a CAGR of nearly 5.2%, during the forecast period.
COVID-19 is expected to have a significant impact on the growth of the market during the pandemic period. The volume of surgeries has significantly declined during the pandemic, owing to the stringent guidelines by the regulatory authorities to avoid all non-emergent surgeries. According to the article published in the National Institute of Health in October 2021, titled " The impact of COVID-19 on emergency general surgery admissions and operative volumes: A single-center experience," there has been a 42.8% decline in general surgery admission across the globe. Thus the non-vascular stents devices market has been significantly impacted by COVID-19.
Certain factors that are driving the market growth include the growing geriatric population and the prevalence of chronic and other diseases, and technological developments in non-vascular stents. According to the International Foundation for Gastrointestinal Disorders 2022 updates, it's estimated that 5-10% of the population has inflammatory bowel disease worldwide. Gastroenterologist visits in the United States were found to be 2.4 to 3.5 million yearly. Such factors are likely to boost the adoption of nonvascular stents, thereby contributing to the growth of the market.
According to the World Health Organization (WHO) data published in October 2021, By 2030, 1 in 6 people in the world will be aged 60 years or over. The share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion by 2030. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. Thus, the aging population increases the demand for non-vascular stents as the geriatric population are prone to developing chronic diseases.
Thus the rising prevalence of various diseases is expected to boost the rise in demand for non-vascular stents.
Non-vascular Stents Industry Segmentation
As per the scope, non-vascular stents refer to a family of devices for a variety of applications, including biliary, colonic, oesophageal, bronchial and tracheal implantations. The Non-vascular Stents Market is segmented by Product Type (Gastrointestinal Stents, Pulmonary (Airway) Stents, Urological Stents, Others), Material Type (Metallic Stents, Non-metallic Stents), End-User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
By Product Type | |
Gastrointestinal Stents | |
Pulmonary (Airway) Stents | |
Urological Stents | |
Others |
By Material Type | |
Metallic Stents | |
Non-metallic Stents |
By End-User | |
Hospitals | |
Ambulatory Surgical Centers |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Non-vascular Stents Market Size Summary
The non-vascular stents market is poised for steady growth, driven by an increasing geriatric population and the rising prevalence of chronic diseases. Technological advancements in stent design and functionality are further propelling market expansion. The demand for non-vascular stents is particularly influenced by the high incidence of urological conditions, such as benign prostatic hyperplasia and urinary tract infections, which are prevalent globally. Additionally, the growing diabetic population is contributing to complications that necessitate the use of these medical devices. The market's trajectory was notably affected by the COVID-19 pandemic, which led to a significant decline in surgical procedures, thereby impacting the adoption of non-vascular stents. However, as healthcare systems recover and elective surgeries resume, the market is expected to regain momentum.
The competitive landscape of the non-vascular stents market is characterized by the presence of major players such as Becton, Dickinson and Company, Boston Scientific Corporation, and Medtronic, among others. These companies hold substantial market shares and are actively involved in expanding their product offerings through regulatory approvals and innovations. For instance, Boston Scientific Corporation received CE mark approval for an expanded indication of its biliary stent, highlighting the ongoing advancements in stent technology. The market's growth is further supported by the increasing need for surgical interventions, such as hernia repairs, which drive the demand for gastrointestinal stents. As the prevalence of conditions requiring non-vascular stents continues to rise, the market is expected to experience sustained growth over the forecast period.
Global Non-vascular Stents Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Geriatric Population and Prevalence of Chronic and Other Diseases
-
1.2.2 Technological Developments in Non-Vascular Stents
-
-
1.3 Market Restraints
-
1.3.1 Complications Associated with Non-Vascular Stents
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product Type
-
2.1.1 Gastrointestinal Stents
-
2.1.2 Pulmonary (Airway) Stents
-
2.1.3 Urological Stents
-
2.1.4 Others
-
-
2.2 By Material Type
-
2.2.1 Metallic Stents
-
2.2.2 Non-metallic Stents
-
-
2.3 By End-User
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Global Non-vascular Stents Market Size FAQs
What is the current Global Non-vascular Stents Market size?
The Global Non-vascular Stents Market is projected to register a CAGR of 5.20% during the forecast period (2024-2029)
Who are the key players in Global Non-vascular Stents Market?
Medtronic, Becton, Dickinson and Company, Boston Scientific Corporation, ELLA - CS, s.r.o. and CONMED Corporation are the major companies operating in the Global Non-vascular Stents Market.